Bioptik Technology (4161) — Cash Flow Quality Index
Bioptik Technology (4161) has a Cash Flow Quality Index of 2.03x as of December 2025. Operating cash flow of NT$53.21 Million exceeds net income of NT$26.24 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of Bioptik Technology to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bioptik Technology Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bioptik Technology across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Bioptik Technology.
Annual Cash Flow Quality Index for Bioptik Technology (2018–2025)
Year-by-year earnings quality comparison for Bioptik Technology.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | NT$59.99 Million | NT$71.19 Million | ▼ -50.4% |
| 2024 | 1.70x | NT$158.82 Million | NT$93.57 Million | ▼ -12.3% |
| 2023 | 1.93x | NT$205.95 Million | NT$106.47 Million | ▲ +120.7% |
| 2022 | 0.88x | NT$55.06 Million | NT$62.81 Million | ▲ +141.8% |
| 2021 | -2.10x | NT$-41.15 Million | NT$19.62 Million | ▼ -126.8% |
| 2019 | 7.81x | NT$41.03 Million | NT$5.25 Million | ▲ +393.0% |
| 2018 | 1.59x | NT$41.83 Million | NT$26.39 Million | — |